DENVER, Colo. (247marketnews.com) -- A fresh round of corporate announcements is highlighting several of Wall Street's strongest investment themes.
PharmAla Biotech and Jupiter Neurosciences
PharmAla Biotech and Jupiter Neurosciences (NASDAQ:JUNS) announced a definitive licensing agreement valued at up to approximately US$100 million, granting Jupiter exclusive perpetual U.S. rights to develop, manufacture and commercialize PharmAla's lead investigational drug candidate, ALA-002. The agreement includes an upfront payment, potential development and commercialization milestones, and future royalty payments, while PharmAla retains all rights to the asset outside the United States.
ALA-002 is a patented, non-racemic MDMA formulation that has received FDA New Chemical Entity designation and is being developed for neuropsychiatric disorders. The agreement expands Jupiter's central nervous system pipeline alongside its lead Parkinson's disease program, JOTROL™, while allowing PharmAla to advance international development without assuming the full cost of U.S. clinical commercialization. As with all investigational drug candidates, future success remains subject to clinical, regulatory and financing milestones.
Kraig Biocraft Laboratories
Kraig Biocraft Laboratories (OTCQB:KBLB) continues gaining commercial visibility as its recombinant spider silk technology moves closer to large-scale production. CEO Kim Thompson was recently featured in Just Style, a leading global apparel trade publication, where he discussed the company's production progress and commercialization strategy with executives across the textile and apparel industries.
During the interview, Thompson outlined Kraig Labs' production growth from laboratory-scale output to approximately 2.5 metric tons of recombinant spider silk cocoon, while identifying a target of reaching 10 metric tons per month. The company continues emphasizing its "plug-and-play" manufacturing model, which leverages existing global silk production infrastructure, potentially reducing barriers to commercial adoption across luxury fashion and advanced textile markets.
KIDZ AI
KIDZ AI (NASDAQ:KIDZ) announced a definitive $44.6 million, five-year GPU compute services agreement with AI inference platform Canopy Wave, marking another step in the company's expansion beyond education technology into enterprise AI infrastructure. Subject to hardware procurement conditions, the agreement calls for deployment of a dedicated cluster featuring 256 NVIDIA HGX Blackwell B300 GPUs to support high-performance AI inference workloads.
The transaction reflects KIDZ AI's strategy of combining long-term contracted enterprise demand with purpose-built AI infrastructure instead of speculative GPU capacity. Management believes growing adoption of open-weight AI models is driving demand for cost-efficient inference computing, positioning the company to participate in one of artificial intelligence's fastest-growing infrastructure segments.
Highway Holdings
Highway Holdings (NASDAQ:HIHO) reported a strong opening quarter for fiscal 2027, delivering 29% year-over-year revenue growth, a 58% increase in gross profit, expanding gross margins and a return to operating profitability. Gross margin improved to approximately 42%, while operating income increased by nearly $200,000 compared to the prior-year quarter.
The company continues repositioning its business following the loss of a long-standing manufacturing customer in Myanmar by pursuing strategic partnerships and expanding toward a more product-focused operating model. Supported by nearly $3.9 million in cash and a solid balance sheet, Highway believes it is well positioned to pursue disciplined growth opportunities while strengthening long-term profitability.
Vivakor
Vivakor (NASDAQ:VIVK) continues expanding its integrated energy logistics platform after announcing four new recurring physical crude oil purchase and sale transactions through Vivakor Supply & Trading. The agreements increase recurring marketed volumes to approximately 300,000 barrels per month, representing 3.6 million barrels annually and an estimated $289 million in annualized commercial activity based on current commodity prices.
Combined with previously announced commercial programs, Vivakor's recurring commercial activity now exceeds approximately $709 million annually, covering roughly 8.1 million barrels of marketed crude oil. The expansion strengthens the company's vertically integrated strategy, combining physical crude marketing with transportation, storage and terminaling assets while broadening commercial relationships across major U.S. energy hubs.
Utz Brands
Utz Brands (NYSE:UTZ) announced a definitive agreement to be acquired by Germany's Intersnack Group in an all-cash transaction valued at approximately $2.9 billion. Shareholders will receive $14.25 per share, representing approximately a 91% premium over the company's prior closing price.
Following completion of the transaction, Utz will become a privately held company jointly owned by Intersnack and the Rice and Lissette family, each holding a 50% ownership stake. The acquisition provides Intersnack with immediate access to the U.S. snack food market while giving Utz expanded resources to support future innovation and growth. The transaction is expected to close during the fourth quarter of 2026, subject to customary shareholder and regulatory approvals.
Sources
· https://jupiterneurosciences.com/
· https://www.highwayholdings.com/
· https://www.intersnackgroup.com/
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, [email protected] to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider and the editor of this article holds a personal investment position in XERI, which may be considered a potential conflict of interest. Readers are encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.
Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.
For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/
CONTACT:
24/7 Market News
[email protected]
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.